Argireline (Acetyl Hexapeptide-3)

Argireline (Acetyl Hexapeptide-3) is a synthetic peptide designed to mimic the N-terminal sequence of SNAP-25, a protein component of the SNARE complex essential for neurotransmitter release at the neuromuscular junction. By interfering with SNARE complex assembly, Argireline reduces the intensity of facial muscle contractions that cause expression wrinkles.

The mechanism parallels that of botulinum toxin, which also targets SNARE proteins but through enzymatic cleavage rather than competitive binding. This has led to Argireline being marketed as a topical alternative to injectable neurotoxins, though its effects are considerably milder due to limited skin penetration.

Research has demonstrated Argireline can reduce the depth of wrinkles around the eyes (crow's feet) and forehead when applied topically at concentrations of 5-10%. The effect requires consistent application over several weeks and reverses upon discontinuation, reflecting the competitive rather than destructive mechanism.

As a cosmetic peptide, Argireline represents the class of signal-modulating peptides that influence cellular communication rather than directly stimulating matrix synthesis. Its safety profile and non-invasive delivery have made it one of the most commercially successful cosmetic peptides.